Four circulating vaccine-derived poliovirus type 1 (cVDPV1) cases were recorded in Ihorombe, Boeni, Sofia and Haute Matsiatra, while the DR of Congo also reported two patients with type 1 in Haut Lomami and Haut Katanga, plus eight cVDPV2 patients in four provinces. Other countries notifying the GPEI of cVDPV2 cases were Côte d’Ivoire (Tchologo) and Mali (two in Gao). Lastly, cVDPV2 positive environmental samples were collected in Egypt (North Sinai) and Mbeya, Tanzania. A Sept 10 WHO regional report on the situation in Tanzania noted that ‘the presence of low population immunity against type 2 poliovirus and the ongoing population movement could potentially increase the public health risk’. Read more
Advice for travellers
Poliomyelitis is a potentially serious viral illness that is spread through contact with infected faeces or saliva. The risk to travellers is generally low, however vaccination is recommended for travel to affected regions and is a requirement for travel to/from some countries. If at risk, adults should have a booster to the childhood series. More on polio.
Before you travel, call Travelvax Australia’s telephone advisory service on 1300 360 164 (toll-free from landlines) for country-specific advice and information. You can also make an appointment at your nearest Travelvax clinic to obtain vaccinations, medication to prevent or treat illness, and accessories for your journey.